MTNB

Matinas Biopharma Holdings (MTNB)

About Matinas Biopharma Holdings (MTNB)

Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of delivering groundbreaking therapies using lipid nanocrystal platform delivery technology to maximize global clinical impact and patient access. The company was founded by Herbert J. Conrad and Jerome D. Jabbour in May 2013 and is headquartered in Bedminster, NJ.

Details

Daily high
$0.57
Daily low
$0.53
Price at open
$0.56
52 Week High
$21.50
52 Week Low
$0.50
Market cap
2.8M
Dividend yield
0.00%
Volume
63,489
Avg. volume
76,434
P/E ratio
-.12

Matinas Biopharma Holdings News

Details

Daily high
$0.57
Daily low
$0.53
Price at open
$0.56
52 Week High
$21.50
52 Week Low
$0.50
Market cap
2.8M
Dividend yield
0.00%
Volume
63,489
Avg. volume
76,434
P/E ratio
-.12